Australia markets closed

Roche Holding AG (RHHVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
384.08-8.92 (-2.27%)
At close: 3:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
59,755,000
58,323,000
61,466,000
56,846,000
53,299,000
Cost of revenue
17,384,000
16,177,000
18,351,000
17,269,000
18,179,000
Gross profit
42,371,000
42,146,000
43,115,000
39,577,000
35,120,000
Operating expenses
Research development
13,774,000
13,009,000
12,774,000
12,092,000
11,292,000
Selling general and administrative
12,958,000
12,614,000
15,078,000
15,367,000
13,272,000
Total operating expenses
24,389,000
23,603,000
25,567,000
24,834,000
22,117,000
Operating income or loss
17,982,000
18,543,000
17,548,000
14,743,000
13,003,000
Interest expense
478,000
553,000
791,000
744,000
765,000
Income before tax
17,671,000
17,965,000
16,614,000
14,148,000
12,248,000
Income tax expense
2,852,000
2,897,000
2,506,000
3,283,000
3,423,000
Income from continuing operations
14,819,000
15,068,000
14,108,000
10,865,000
8,825,000
Net income
14,019,000
14,295,000
13,497,000
10,500,000
8,633,000
Net income available to common shareholders
14,019,000
14,295,000
13,497,000
10,500,000
8,633,000
Basic EPS
-
16.73
15.77
12.29
10.12
Diluted EPS
-
16.52
15.62
12.21
10.04
Basic average shares
-
855,000
856,000
854,000
853,000
Diluted average shares
-
865,000
864,000
860,000
860,000
EBITDA
-
23,076,000
21,697,000
18,478,000
16,900,000